Daré Bioscience Reports Full Year 2020 Financial Results and Provides a Company Update
Conference Call and Webcast Today at 4:30 p.m. Eastern TimeSAN DIEGO, March 30, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:...
Staff
I-Mab and ABL Bio Receive US FDA Approval to Initiate Phase 1 Trial of Bispecific Antibody TJ-CD4B/ABL111 in Patients with Advanced or Metastatic Solid Tumors
SHANGHAI, China and GAITHERSBURG, Md., March 30, 2021 (GLOBE NEWSWIRE) -- I-Mab (the “Company”) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company...
Philips receives high score for its ESG practices from S&P Global Ratings
Refurbishment Process MRI Bouwdokken CLC South-Africa March 30, 2021 Philips received a score of 90 out of 100, the...
T2 Biosystems CEO Shares Personal Heart Transplant and Sepsis Survival Story in Newly Released Book
All proceeds from the book sale will be donated to Sepsis Alliance and Donate Life America LEXINGTON, Mass., March 30,...
GCAC First Commercial Software Sale Cash Deposit
Company Marks Transition from Technology Concept to Commercial RealityVANCOUVER, British Columbia, March 30, 2021 (GLOBE NEWSWIRE) -- Global Cannabis Applications...
MiMedx Awarded Amniotic Tissue Supplier Agreement with Premier® Inc.’s SURPASS™ Purchasing Program
MARIETTA, Ga., March 30, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader...
Krystal Biotech Announces Completion of Patient Enrollment in the GEM-3 Pivotal Trial of B-VEC for the Treatment of Dystrophic Epidermolysis Bullosa
PITTSBURGH, March 30, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for...
Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics
-- New round enables Pyxis to advance differentiated antibody-drug conjugate (ADC) and immuno-oncology (I/O) programs to next value inflection point...
Vivos Therapeutics to Launch MyoCorrect Orofacial Myofunctional Therapy Service
Vivos to offer MyoCorrect via telemedicine for all Vivos-trained clinicians to use as therapeutic protocol in tandem with the Vivos...
Histogen to Present at the 20th Annual Needham Virtual Healthcare Conference
SAN DIEGO, March 30, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential...
Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2021 DDW Annual Meeting
REDWOOD CITY, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company” or “Allakos”) (Nasdaq: ALLK), a biotechnology company...
Ovid Therapeutics Announces Closing of Agreement with Takeda for Global Development and Commercialization of Soticlestat
NEW YORK, March 30, 2021 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID) (“Ovid”), a biopharmaceutical company committed to developing...
BioCardia Reports 2020 Financial Results and Recent Business Highlights
SAN CARLOS, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a leader in the development of comprehensive solutions for...
Tiziana Announces the FDA Has Allowed Treatment for a Secondary Progressive Multiple Sclerosis (SPMS) Patient for the Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, Under an Individual Patient Expanded Access Program
NEW YORK and LONDON, March 30, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA, LSE: TILS) (“Tiziana” or...
Turkish Ministry of Health Approves Increase in Patient Recruitment into the Phase II Trial for LSALT Peptide
TORONTO, March 30, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF),...
Kiadis EGM adopts all resolutions related to the recommended public offer by Sanofi
This is a press release by Kiadis Pharma N.V. (“Kiadis”) in connection with the public offer by Sanofi Foreign Participations...
Tiziana Life Sciences plc: Accustem Update
NEW YORK and LONDON, March 30, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences. (NASDAQ: TLSA; LSE: TILS), a biotechnology company...
Acerus Announces Expansion of NATESTO® Distribution Worldwide
Maylen Farma to Market Treatment in 20 Countries across Europe, Central Asia and the Middle EastTORONTO, March 30, 2021 (GLOBE...
Evaxion Biotech to Host Full-Year 2020 Corporate Update Conference Call & Webcast on April 6
COPENHAGEN, Denmark, March 30, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (Nasdaq: EVAX), a clinical-stage biotechnology company specializing in the...
Intellia Therapeutics’ Investigational CRISPR Treatment NTLA-2001 Receives European Union Orphan Drug Designation for ATTR Amyloidosis
CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing...